July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Beliefs and Attitudes of Ophthalmologists Regarding Selective Laser Trabeculoplasty as First Line Therapy for Glaucoma
Author Affiliations & Notes
  • Lucas Bonafede
    Glaucoma Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Judie Tran
    Glaucoma Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Lisa A Hark
    Department of Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Carina Sanvicente
    Glaucoma Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Qiang Zhang
    Biostatistics Consulting Core, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Rose Costello
    Biostatistics Consulting Core, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • L. Jay Katz
    Glaucoma Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Lucas Bonafede, None; Judie Tran, None; Lisa Hark, None; Carina Sanvicente, None; Qiang Zhang, None; Rose Costello, None; L. Katz, None
  • Footnotes
    Support  The Glaucoma Research Foundation
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2829. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lucas Bonafede, Judie Tran, Lisa A Hark, Carina Sanvicente, Qiang Zhang, Rose Costello, L. Jay Katz; Beliefs and Attitudes of Ophthalmologists Regarding Selective Laser Trabeculoplasty as First Line Therapy for Glaucoma. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2829. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Selective laser trabeculoplasty (SLT) is a safe and effective first line treatment for glaucoma, however, it is underutilized for this purpose. To evaluate barriers for the widespread adoption of this procedure, we assessed the beliefs and attitudes of ophthalmologists regarding SLT. We developed an educational slide presentation directed to physicians to increase the consideration of SLT earlier in the glaucoma treatment paradigm.

Methods : In this prospective study, an online survey and educational slide presentation was sent to a group of general ophthalmologists, ophthalmology residents, and glaucoma specialists in the Wills Eye Hospital physician contact database. Subjects were asked to respond to questions regarding their beliefs and attitudes towards SLT, before and after watching the educational slide presentation. Responses were compared between physician specialty groups.

Results : A total of 53 subjects were enrolled. Prior to watching the slide presentation, 85% of participants stated they offer SLT to newly diagnosed patients, although only 26% preferred SLT over glaucoma medications (66%) or other treatments (8%). Although 52% of physicians reported between 0 – 10% of their newly diagnosed patients receive SLT, 47% said they would use SLT as a first line therapy for all or most newly diagnosed glaucoma patients, with good compliance (30%) and efficacy (28%) being the most commonly cited as reasons to use SLT as a first line therapy, and patient hesitancy (17%) the most common reason not to choose SLT.

Most participants (94%) stated the educational slide presentation convinced them that SLT is appropriate as a first line therapy, reporting safety (53%), efficacy (51%), and adherence (49%) as the main reasons. Following the educational slide presentation, 32% of physicians were still reluctant to prescribe SLT as a first line treatment. Significant differences between specialty groups are shown on Table 1.

Conclusions : A better understanding of the different barriers for utilizing SLT as a first-line therapy provides valuable information to help increase the adoption of this safe and effective procedure.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×